<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmtech.com/view/overton-withdrawal-extends-fda-leadership-vacuum-for-drug-sponsors</loc>
      <lastmod>2026-11-18T15:32:36.626Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T15:32:36.626Z</news:publication_date>
        <news:title><![CDATA[Overton Withdrawal Extends FDA Leadership Vacuum for Drug Sponsors]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/cphi-awards-winner-for-manufacturing-excellence-anemocyte-and-mrna-synthesis</loc>
      <lastmod>2026-11-18T14:09:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T14:09:00Z</news:publication_date>
        <news:title><![CDATA[CPHI Awards Winner for Manufacturing Excellence: Anemocyte and mRNA Synthesis]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/neladalkib-accelerated-approval-what-alk-drug-developers-should-know</loc>
      <lastmod>2026-11-17T22:06:03.418Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T22:06:03.418Z</news:publication_date>
        <news:title><![CDATA[Neladalkib Accelerated Approval: What ALK Drug Developers Should Know]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/challenges-in-oral-delivery-of-peptides-scale-up</loc>
      <lastmod>2026-11-17T20:06:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T20:06:00Z</news:publication_date>
        <news:title><![CDATA[Challenges in Oral Delivery of Peptides: Scale Up]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/challenges-in-oral-delivery-of-peptides-bioavailability</loc>
      <lastmod>2026-11-17T17:55:03.208Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T17:55:03.208Z</news:publication_date>
        <news:title><![CDATA[Challenges in Oral Delivery of Peptides: Bioavailability]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/giredestrant-takes-esr1-breast-cancer-treatment-into-oral-solid-doses</loc>
      <lastmod>2026-11-17T15:26:04.729Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T15:26:04.729Z</news:publication_date>
        <news:title><![CDATA[Giredestrant Takes ESR1 Breast Cancer Treatment Into Oral Solid Doses]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/manufacturing-intelligence-where-pharma-should-slow-ai</loc>
      <lastmod>2026-11-17T12:30:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T12:30:00Z</news:publication_date>
        <news:title><![CDATA[Manufacturing Intelligence: Where Pharma Should Slow AI]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/the-hidden-cost-of-clinical-supply-unlocking-study-cash-flow-and-flexibility</loc>
      <lastmod>2026-11-17T05:53:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T05:53:00Z</news:publication_date>
        <news:title><![CDATA[The Hidden Cost of Clinical Supply: Unlocking Study Cash Flow and Flexibility]]></news:title>
        <news:keywords><![CDATA[webcasts]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/astrazeneca-secures-2-fda-approvals-bladder-cancer-myasthenia-gravis</loc>
      <lastmod>2026-11-16T20:52:47.949Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T20:52:47.949Z</news:publication_date>
        <news:title><![CDATA[AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis]]></news:title>
      </news:news>
	</url></urlset>